周生生(00116.HK)終止經營證券及期貨經紀業務
格隆匯1月29日丨周生生(00116.HK)公佈,集團一直從事證券及期貨經紀業務。過去數年,集團所經營的證券及期貨經紀業務以至其同業的香港中小型證券公司一直在日益嚴峻及具挑戰性的營商環境下營運。
公司董事會一直密切監察並檢討證券及期貨經紀業務的營運及表現。經考慮營商環境的挑戰性與日俱增及證券及期貨經紀業務的整體表現及其相對於集團其他業務的表現,董事會決定終止經營證券及期貨經紀業務。董事會認為終止能使集團能更妥善地重新分配及使用其資源至集團的其他核心業務,尤其是珠寶製造及零售分部。監於上文所述,董事會認為終止符合公司及其股東的整體最佳利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.